Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimisation of Catheter Navigation With As Low As Reasonable Achievable Fluoroscopy for Amelioration of Ablation Success in Patients With SupraVentricular Tachycardia (ALARA-SVT)

NCT02743325 is registered in ClinicalTrials.gov with Richard Kobza as lead sponsor.

NCT NCT02743325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02743325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimisation of Catheter Navigation With As Low As Reasonable Achievable Fluoroscopy for Amelioration of Ablation Success in Patients With SupraVentricular Tachycardia (ALARA-SVT)
Lead sponsor
Richard Kobza
Phase
Not applicable
Overall status
Completed
Start date
April 25, 2016
Completion date
December 31, 2018
Enrollment
60 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic supraventricular tachycardia